The utility of copy number variation (CNV) in studies of hypertension-related left ventricular hypertrophy (LVH): Rationale, potential and challenges
The ultimate goal of human genetics is to understand the role of genome variation in elucidating human traits and diseases. Besides single nucleotide polymorphism (SNP), copy number variation (CNV), defined as gains or losses of a DNA segment larger than 1 kb, has recently emerged as an important to...
Main Authors: | Boon-Peng, H. (Author), Yusoff, K. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
BioMed Central Ltd.
2013
|
Subjects: | |
Online Access: | View Fulltext in Publisher View in Scopus |
Similar Items
-
Rare copy number variants identified suggest the regulating pathways in hypertension-related left ventricular hypertrophy
by: Basir, F., et al.
Published: (2016) -
Compelling therapy of LVH: straight (and not-so-straight) inferences from evidence
by: Ravi Tejraj Mehta, et al.
Published: (2019-11-01) -
Anti-hypertensive drugs have different effects on ventricular hypertrophy regression
by: Celso Ferreira Filho, et al.
Published: (2010-01-01) -
The effect of intensive hemodialysis on LVH regression and blood pressure control in ESRD patients
by: Forough Darabi, et al.
Published: (2020-01-01) -
Effect of fosinopril on progression of the asymptomatic carotid atherosclerosis and left ventricular hypertrophy in hypertensive patients
by: Tasić Ivan, et al.
Published: (2006-01-01)